Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir
详细信息    查看全文
文摘

Differences between HCV RNA assays might influence treatment decisions.

Concordance of 3 real-time PCR-based HCV RNA assays was tested.

Plasma samples from Phase III simeprevir/PegIFN/RBV studies (HCV genotype 1 and 4) were used.

Inter-assay concordance was generally good, except in low viremic samples at early time points.

An HCV RNA threshold <25 IU/mL was more assay-independent than RNA undetectability.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700